Clinical Trial Update: A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating capecitabine (Xeloda) in combination with peginterferon alfa-2a (Pegasys) in treatment-naive participants with advanced hepatocellula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED